Michael S. Niederman

Active 1983–2026

107
Papers
28,265
Citations
82
h-index
104
i10-index

Citations

Citations per year for Michael S. Niederman1977: 2 citations1984: 6 citations1986: 5 citations1987: 1 citations1988: 6 citations1989: 7 citations1990: 20 citations1991: 12 citations1992: 11 citations1993: 17 citations1994: 15 citations1995: 31 citations1996: 41 citations1997: 49 citations1998: 61 citations1999: 61 citations2000: 105 citations2001: 113 citations2002: 108 citations2003: 156 citations2004: 130 citations2005: 163 citations2006: 156 citations2007: 141 citations2008: 187 citations2009: 214 citations2010: 171 citations2011: 185 citations2012: 171 citations2013: 151 citations2014: 135 citations2015: 129 citations2016: 149 citations2017: 120 citations2018: 146 citations2019: 473 citations2020: 464 citations2021: 494 citations2022: 371 citations2023: 336 citations2024: 633 citations2025: 283 citations2026: 12 citations1978–1983: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,863 citing papers, 24.4% of this breakdownChina: 615 citing papers, 8% of this breakdownSpain: 583 citing papers, 7.6% of this breakdownFrance: 441 citing papers, 5.8% of this breakdownUnited Kingdom: 428 citing papers, 5.6% of this breakdownItaly: 322 citing papers, 4.2% of this breakdownGermany: 266 citing papers, 3.5% of this breakdownCanada: 242 citing papers, 3.2% of this breakdownAustralia: 226 citing papers, 3% of this breakdownJapan: 191 citing papers, 2.5% of this breakdownNetherlands: 182 citing papers, 2.4% of this breakdownSwitzerland: 180 citing papers, 2.3% of this breakdown
0%24.4%Other 27.5%

Fields

  • Medicine75.5%
  • Biochemistry, Genetics and Molecular Biology10.5%
  • Immunology and Microbiology6.6%
  • Health Professions3.1%
  • Engineering0.7%
  • Environmental Science0.6%
  • Other3%

Topics

  • Pneumonia and Respiratory Infections13.1%
  • Nosocomial Infections in ICU11.6%
  • Sepsis Diagnosis and Treatment5%
  • Antibiotic Use and Resistance5%
  • Antibiotic Resistance in Bacteria5%
  • Respiratory viral infections research3.5%
  • Other56.8%

Coauthors

All papers

Open in search
  1. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 1,395

  2. Pneumonia

    Authors: , , , , , , - Nature Reviews Disease Primers 2021 cited by 806

  3. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2007 cited by 6,244

  4. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2023 cited by 285

  5. Aspiration Pneumonia

    Authors: , - New England Journal of Medicine 2019 cited by 612

  6. Initial antimicrobial management of sepsis

    Authors: , , , , , , , , - Critical Care 2021 cited by 175

  7. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takaya Maruyama, Rosario Menéndez, Mark L. Metersky, Donna Mildvan, Eric M. Mortensen, Michael S. Niederman, Mathias W. Pletz, Jordi Rello, Marcos I. Restrepo, Yuichiro Shindo, Antoní Torres, Grant Waterer, Brandon Webb, Tobias Welte, Martin Witzenrath, Richard G. Wunderink - CHEST Journal 2020 cited by 233

  8. Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response

    Authors: , , , , , , , , , , , - JAMA 2015 cited by 564

  9. The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States

    Authors: , , , , , , - CHEST Journal 2020 cited by 121

  10. Challenges in severe community-acquired pneumonia: a point-of-view review

    Authors: , , , , , , , - Intensive Care Medicine 2019 cited by 193

  11. Updates on community acquired pneumonia management in the ICU

    Authors: , - Pharmacology & Therapeutics 2020 cited by 195

  12. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

    Authors: , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2019 cited by 131

  13. Management of pneumonia in critically ill patients

    Authors: , , - BMJ 2021 cited by 171

  14. Severe community-acquired pneumonia

    Authors: , - European Respiratory Review 2022 cited by 110

  15. Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*

    Authors: , , , , , , , , , , - Critical Care Medicine 2014 cited by 207

  16. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonios Papadopoulos, Michael S. Niederman - The Lancet Respiratory Medicine 2024 cited by 60

  17. Guidelines for the Management of Adults with Community-acquired Pneumonia

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2001 cited by 2,170

  18. Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

    Authors: , , , , , , , , - Clinical Infectious Diseases 2012 cited by 573

  19. Community-acquired pneumonia related to intracellular pathogens

    Authors: , , , , , , - Intensive Care Medicine 2016 cited by 126

  20. Microbiology of Ventilator–Associated Pneumonia Compared With That of Hospital-Acquired Pneumonia

    Authors: , , , , , - Infection Control and Hospital Epidemiology 2007 cited by 186

  21. The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia

    Authors: , , , , , , , - Annals of the American Thoracic Society 2016 cited by 121

  22. Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa

    Authors: , , , , , , , - CHEST Journal 2016 cited by 118

  23. Future Research Directions in Pneumonia. NHLBI Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 89

  24. Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome*

    Authors: , , , , , , , , , - Critical Care Medicine 2003 cited by 489